IP Library Assignment 021744/0652
Patent Assignment
Reel/Frame 021744/0652

Security Agreement

Recorded: 2008-10-28 Pages: 20
Assignor
AVALON PHARMACEUTICALS, INC.
Executed: 2008-10-27
Assignee
CLINICAL DATA, INC.
ONE GATEWAY CENTER, SUITE 702, NEWTON, MASSACHUSETTS, 02458
Covered Properties (44)
Multi-Ring Compounds and Uses Thereof
Derivatives of Fluorene, Anthracene, Xanthene, Dibenzosuberone and Acridine and Uses Thereof
Cancer gene determination and therapeutic screening using signature gene sets
Application: 09/873,367 →
Publication: US 2003/0165839
Process for identifying anti-cancer therapeutic agents using cancer gene sets
Application: 09/954,456 →
Publication: US 2002/0115057
Process for identifying anti-cancer therapeutic agents using cancer gene sets
Application: 09/954,531 →
Publication: US 2002/0165180
Inhibitors of Impdh Enzyme
Patent: 6,498,178 →
Application: 09/955,626 →
Publication: US 2002/0111378
Cancer gene determination and therapeutic screening using signature gene sets
Application: 09/962,436 →
Publication: US 2002/0081301
Cancer gene determination and therapeutic screening using signature gene sets
Application: 09/962,832 →
Publication: US 2002/0110821
Cancer gene determination and therapeutic screening using signature gene sets
Application: 09/964,824 →
Publication: US 2002/0102531
Cancer gene determination and therapeutic screening using signature gene sets
Application: 09/967,768 →
Publication: US 2002/0150877
Cancer gene determination and therapeutic screening using signature gene sets
Application: 09/968,007 →
Publication: US 2004/0115625
Cancer gene determination and therapeutic screening using signature gene sets
Application: 09/969,347 →
Publication: US 2002/0115085
Cancer gene determination and therapeutic screening using signature gene sets
Application: 09/969,708 →
Publication: US 2002/0102532
Agents for Regulation of Colon Cancer Gene Expression
Patent: 6,548,539 →
Application: 10/090,866 →
Inhibitors of Impdh Enzyme
Patent: 7,087,642 →
Application: 10/287,405 →
Publication: US 2004/0029939
Cancer-linked gene as target for chemotherapy
Application: 10/378,973 →
Publication: US 2004/0001840
Cancer-linked gene as target for chemotherapy
Application: 10/379,632 →
Publication: US 2003/0219382
Cancer-linked gene as target for chemotherapy
Application: 10/382,600 →
Publication: US 2003/0219799
Cancer-linked gene as target for chemotherapy
Application: 10/383,368 →
Publication: US 2004/0002091
Cancer-linked genes as targets for chemotherapy
Application: 10/399,225 →
Publication: US 2004/0072192
Cancer-linked gene as target for chemotherapy
Application: 10/514,534 →
Publication: US 2005/0287147
Cancer-linked gene as target for chemotherapy
Application: 10/514,535 →
Publication: US 2006/0110731
Cancer-linked gene as target for chemotherapy
Application: 10/516,476 →
Publication: US 2005/0220798
Cancer-linked gene as target for chemotherapy
Application: 10/516,697 →
Publication: US 2006/0228705
Cancer-linked gene as target for chemotherapy
Application: 10/518,039 →
Publication: US 2006/0099214
Amplified cancer target genes useful in diagnosis and therapeutic screening
Application: 10/540,311 →
Publication: US 2006/0134622
Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methods
Application: 10/553,098 →
Publication: US 2007/0059697
Identification of Therapeutic Agents Using Genetic Fingerprinting
Application: 10/561,372 →
Publication: US 2007/0270504
Chemo-Centric Selection of Disease-Related Genetic Profiles
Patent: 7,427,473 →
Application: 10/590,256 →
Publication: US 2007/0184447
Determining Cancer-Linked Genes and Therapeutic Targets Using Molecular Cytogenetic Methods
Application: 10/591,049 →
Publication: US 2008/0305493
Derivatives of 3-Hydroxy-Pyrrole-2,4-Dicarboxylic Acid and Uses Thereof
Patent: 7,094,791 →
Application: 10/631,887 →
Publication: US 2005/0026991
Compositions Comprising Inhibitors of Impdh Enzyme
Patent: 7,943,593 →
Application: 10/728,114 →
Publication: US 2005/0059734
Diamine derivatives of quinone and uses thereof
Application: 10/758,521 →
Publication: US 2005/0032794
Inhibitors of Impdh Enzyme
Patent: 7,432,290 →
Application: 10/997,810 →
Publication: US 2005/0148644
Polymorphic Forms of (S)-1-Cyanobutan-2-Yl (S)-1-(3-(3-(3-Methoxy-4- (Oxazol-5-Yl)Phenyl) Ureido)Phenyl) Ethylcarbamate
Patent: 7,504,515 →
Application: 11/440,891 →
Publication: US 2007/0099972
Biomarkers for Monitoring Impdh Pathway Inhibition
Application: 11/597,464 →
Publication: US 2008/0318803
Cancer-linked genes as targets for chemotherapy
Application: 11/599,845 →
Publication: US 2008/0025981
Cancer gene determination and therapeutic screening using signature gene sets
Application: 11/881,252 →
Publication: US 2008/0050379
Inhibitors of Impdh Enzyme
Application: 60/125,507 →
Inhibitors of Impdh Enzyme
Application: 60/174,882 →
Composition comprising inhibitors of IMPDH enzyme
Application: 60/431,555 →
Compositions comprising inhibitors of IMPDH enzyme
Application: 60/496,261 →
Biomarkers for monitoring IMPDH pathway inhibition
Application: 60/575,076 →
Polymorphic forms of (S)-1-cyanobutan-2-yl (S)-1-(3-(3-(3-methoxy-4-(oxazol-5- yl)phenyl)ureido)phenyl)ethylcarbamate
Application: 60/684,644 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 30, 2001
From: YOUNG, PAUL E.; SOPPET, DANIEL R.; ENDRESS, GREGORY; AUGUSTUS, MEENA
To: AVALON PHARMACEUTICALS
Reel/Frame 012020/0051 →
Assignment of Assignor's Interest Jan 28, 2002
From: EBNER, REINHARD
To: AVALON PHARMACEUTICALS
Reel/Frame 012563/0550 →
Assignment of Assignor's Interest Jan 29, 2002
From: AUGUSTUS, MEENA
To: AVALON PHARMACEUTICALS, INC.
Reel/Frame 012535/0293 →
Assignment of Assignor's Interest Jan 29, 2002
From: EBNER, REINHARD
To: AVALON PHARMACEUTICALS, INC.
Reel/Frame 012535/0305 →
Assignment of Assignor's Interest Jan 30, 2002
From: AUGUSTUS, MEENA
To: AVALON PHARMACEUTICALS, INC.
Reel/Frame 012566/0938 →
Assignment of Assignor's Interest Jan 30, 2002
From: SOPPET, DANIEL
To: AVALON PHARMACEUTICALS, INC.
Reel/Frame 012560/0507 →
Assignment of Assignor's Interest Feb 4, 2002
From: HORRIGAN, STEVE
To: AVALON PHARMACEUTICALS, INC.
Reel/Frame 012548/0880 →
Assignment of Assignor's Interest Feb 13, 2002
From: HORRIGAN, STEVE
To: AVALON PHARMACEUTICALS, INC.
Reel/Frame 012625/0144 →
Assignment of Assignor's Interest Apr 11, 2002
From: YOUNG, PAUL E.
To: AVALON PHARMACEUTICALS, INC.
Reel/Frame 012784/0164 →
Assignment of Assignor's Interest Apr 11, 2002
From: WEAVER, ZOE
To: AVALON PHARMACEUTICALS, INC.
Reel/Frame 012782/0908 →
Assignment of Assignor's Interest May 15, 2002
From: PIKUL, STANISLAW; SOPPET, DANIEL R.; YOUNG, PAUL E.
To: AVALON PHARMACEUTICALS, INC.
Reel/Frame 012895/0918 →
Assignment of Assignor's Interest Jun 5, 2002
From: EBNER, REINHARD
To: AVALON PHARMACEUTICALS, INC.
Reel/Frame 012970/0751 →
Assignment of Assignor's Interest Jul 14, 2003
From: HORRIGAN, STEPHEN K.; YOUNG, PAUL E.; EBNER, REINHARD
To: AVALON PHARMACEUTICALS, INC.
Reel/Frame 014257/0605 →
Assignment of Assignor's Interest Jul 17, 2003
From: YOUNG, PAUL E.; EBNER, REINHARD; WEAVER, ZOE
To: AVALON PHARMACEUTICALS, INC.
Reel/Frame 014274/0561 →
Assignment of Assignor's Interest Jul 17, 2003
From: YOUNG, PAUL E.; EBNER, REINHARD; STROVEL, JEFFREY W.
To: AVALON PHARMACEUTICALS, INC.
Reel/Frame 014275/0134 →
Assignment of Assignor's Interest Jul 17, 2003
From: YOUNG, PAUL E.; EBNER, REINHARD; WEAVER, ZOE
To: AVALON PHARMACEUTICALS, INC.
Reel/Frame 014275/0187 →
Assignment of Assignor's Interest Nov 7, 2003
From: YOUNG, PAUL E.; HORRIGAN, STEPHEN K.; WEAVER, ZOE; ENDRESS, GREGORY
To: AVALON PHARMACEUTICALS, INC.
Reel/Frame 014670/0504 →
Assignment of Assignor's Interest Jun 28, 2005
From: EBNER, REINHARD
To: AVALON PHARMACEUTICALS, INC.
Reel/Frame 016426/0630 →
Assignment of Assignor's Interest Dec 6, 2005
From: YOUNG, PAUL E.; EBNER, REINHARD
To: AVALON PHARMACEUTICALS, INC.
Reel/Frame 017091/0681 →
Assignment of Assignor's Interest Dec 6, 2005
From: YOUNG, PAUL E.; EBNER, REINHARD
To: AVALON PHARMACEUTICALS, INC.
Reel/Frame 017091/0508 →
Assignment of Assignor's Interest Jan 5, 2006
From: HORRIGAN, STEPHEN K.; EBNER, REINHARD
To: AVALON PHARMACEUTICALS, INC.
Reel/Frame 017163/0030 →
Assignment of Assignor's Interest Jan 26, 2006
From: EBNER, REINHARD; SHEA, MARTIN
To: AVALON PHARMACEUTICALS, INC.
Reel/Frame 017212/0695 →
Assignment of Assignor's Interest Apr 24, 2006
From: RICK, JENNIFER A.; EBNER, REINHARD
To: AVALON PHARMACEUTICALS, INC.
Reel/Frame 017528/0694 →
Assignment of Assignor's Interest Sep 5, 2008
From: OHLER, NORMAN E.; WATTHEY, JEFFREY W.; ZONG, QIN; YOUNG, PAUL E.
To: AVALON PHARMACEUTICALS, INC.
Reel/Frame 021492/0319 →
Assignment of Assignor's Interest Sep 22, 2008
From: CHOLODY, WIESLAW M.; ZANG, YI; GELMAN, KARINA; WATTHEY, JEFFREY W.
To: AVALON PHARMACEUTICALS, INC.
Reel/Frame 021577/0936 →